Abstract:Objective To study the changes in levels of interleukin (IL)-6, IL-10, tumor necrosis factor-alpha (TNF-α), and alkaline phosphatase (ALP) in the gingival crevicular fluid (GCF) of patients with severe chronic periodontitis before and after nonsurgical periodontal therapy and to explore the relationship among the levels of these four biomarkers in GCF, their periodontal status and their clinical significance to evaluate the effect of nonsurgical periodontal therapy and periodontitis activity. Methods In total, 30 patients with severe chronic periodontitis were enrolled in a 1-year longitudinal pilot study (Chinese Clinical Trial Registry: ChiCTR-OCH-13004679). At baseline and 1, 3, 6, and 12 months after nonsurgical therapy, the periodontal clinical indicators plaque index (PLI), probing depth (PD), clinical attachment loss (CAL), sulcus bleeding index (SBI) were recorded. Filter paper strips were used to collect two deep-pocket (probing depth ≥ 6 mm) and two shallow-pocket (probing depth ≤ 4 mm) periodontal sites for each patient and weighed. The levels of interleukin IL-6, IL-10, TNF-α, and ALP in GCF were assessed using enzyme-linked immunosorbent assay. Meanwhile, 30 healthy sites of 15 subjects with healthy periodontium were used as the baseline controls for patients with severe chronic periodontitis. Results At the baseline, the TNF-α, ALP and IL-6 levels in GCF of the disease sites of patients with periodontitis were significantly higher than those in healthy periodontal sites of the control group (P < 0.001), and the levels of IL-10 were significantly lower than those in the control group (P < 0.001). In patients with severe chronic periodontitis, the levels of TNF-α, ALP and IL-6 in GCF at deep-pocket sites were significantly higher than those at shallow-pocket sites (P <0.001), and the IL-10 levels were significantly lower than those at shallow-pocket sites (P < 0.001). 1, 3, 6, and 12 months after nonsurgical treatment, the levels of TNF-α and ALP in GCF at the shallow- and deep-pocket sites in patients with chronic periodontitis significantly decreased, the level of IL-10 significantly increased (P < 0.005), and the level of IL-6 in GCF at the deep-pocket sites significantly decreased (P < 0.005). However, there was no significant difference in IL-6 level at shallow-pocket sites (P > 0.05). 1, 3, 6, and 12 months after nonsurgical treatment, the periodontal clinical indicators were improved compared with the baseline. In addition, there was a significant correlation between the levels of these four biomarkers and the periodontal clinical parameters (P < 0.05). During the two follow-up visits after nonsurgical periodontal therapy, the sites with more than 2-mm increase in attachment loss had significant differences in the levels of the four biomarkers in the GCF compared with the previous visit time (P < 0.005). Conclusion The detection of the levels of these four biomarkers in GCF has strong clinical significance for assessing the severity of periodontitis and the efficacy of nonsurgical periodontal therapy. Increased levels of TNF-α, ALP, and IL-6 and decreased IL-10 levels in GCF may indicate periodontitis progression at this site.

Changes of Oral Flora, Inflammatory Factors, and Immune Function Indicators in Patients with Chronic Periodontitis and Their Clinical Significance

Testing of Periodontal Clinical Indicators and Serum TNF-α Level in Periodontal Patients with Coronary Heart Disease

Association Of Periodontal Parameters With Metabolic Level And Systemic Inflammatory Markers In Patients With Type 2 Diabetes

Cytokine Levels in Plasma and Gingival Crevicular Fluid in Chronic Periodontitis.

The Characteristics of Microbiome and Cytokines in Healthy Implants and Peri-Implantitis of the Same Individuals

Association Between Infection of Different Strains of Porphyromonas Gingivalis and Actinobacillus Actinomycetemcomitans in Subgingival Plaque and Clinical Parameters in Chronic Periodontitis

The effect of periodontal health and disease on interleukin 1β and nesfatin-1 levels in gingival crevicular fluid: A cross-sectional study

Relationship Between Gingival Crevicular Fluid Microbiota and Cytokine Profile in Periodontal Host Homeostasis

Association Between Coinfection Of Porphyromonas Gingivalis, Actinobacillus Actinomycetemcomitans And Treponema Denticola And Periodontal Tissue Destruction In Chronic Periodontitis

Effect of Porphyromonas Gingivalis Prtc on Cytokine Expression in Ecv304 Endothelial Cells and Its Level in Subgingival Plaques from Patients with Chronic Periodontitis

The Changes of IL-17 Levels in Gingival Crevicular Fluid of Chronic Periodontitis Pre-and after Periodental Non-Surgical Treatment

Changes and clinical significance of four biomarkers in gingival crevicular fluid after nonsurgical periodontal therapy

Inflammatory Cytokine Levels in Patients with Periodontitis And/Or Coronary Heart Disease

[Interleukin-1Beta and IL-1 Receptor Antagonist Levels in Gingival Crevicular Fluid and Their Relationship to Clinical Indices of Periodontitis].

Correlation of Chronic Periodontitis in Tropical Area and IFN-γ, IL-10, IL-17 Levels

Biomarker Levels in Gingival Crevicular Fluid of Subjects with Different Periodontal Conditions: A Cross-Sectional Study

[Changes of Circulating IFN-gamma, IL-4 in Patients with Chronic Periodontitis Before and after Periodontal Initial Therapy].

Change of crevicular fluid interleukin-10 level in pre-and after-periodontal therapy in chronic periodontitis

Evaluation of Interleukin-10 Producing CD19+ B Cells in Human Gingival Tissue.

Gene polymorphism and protein of human pro- and anti-inflammatory cytokines in Chinese healthy subjects and chronic periodontitis patients

[Levels of Inflammation Cytokines in Patients with Coronary Heart Disease and Periodontal Disease].